Patents by Inventor Mi Hye KWON

Mi Hye KWON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BLOOD GLUCOSE PREDICTION SYSTEM AND METHOD USING SALIVA-BASED ARTIFICIAL INTELLIGENCE DEEP LEARNING TECHNIQUE
    Publication number: 20240074708
    Abstract: It is disclosed a blood glucose prediction system and method using saliva-based artificial intelligence deep learning technique.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 7, 2024
    Applicant: DONG WOON ANATECH CO., LTD.
    Inventors: In Su Jang, Min Su Kwon, Hee Jung Kwon, Sung Hwan Chung, Eun Hye Im, Ji Won Kye, Eun Hyun Shim, Hee Jin Kim, Mi Rim Kim, Hyun Seok Cho, Dong Cheol Kim
  • Composition for preventing or treating erectile dysfunction comprising angiopoietin-4 protein
    Patent number: 9498516
    Abstract: Provided is a composition for preventing or treating erectile dysfunction including angiopoietin-4 protein as an active ingredient. Angiopoietin-4 protein increases an endothelial cell-specific protein level to induce regeneration of penile vascular endothelial cells, thereby increasing intracavernous pressure. Thus, angiopoietin-4 protein may be efficiently applied to prevention or treatment of erectile dysfunction.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: November 22, 2016
    Assignee: INHA INDUSTRY PARTNERSHIP INSTITUTE
    Inventors: Jun Kyu Suh, Ji Kan Ryu, Mi Hye Kwon, Gou Young Koh
  • COMPOSITION FOR PREVENTING OR TREATING ERECTILE DYSFUNCTION COMPRISING ANGIOPOIETIN-4 PROTEIN
    Publication number: 20140148385
    Abstract: Provided is a composition for preventing or treating erectile dysfunction including angiopoietin-4 protein as an active ingredient. Angiopoietin-4 protein increases an endothelial cell-specific protein level to induce regeneration of penile vascular endothelial cells, thereby increasing intracavernous pressure. Thus, angiopoietin-4 protein may be efficiently applied to prevention or treatment of erectile dysfunction.
    Type: Application
    Filed: November 13, 2013
    Publication date: May 29, 2014
    Applicant: INHA INDUSTRY PARTNERSHIP INSTITUTE
    Inventors: Jun Kyu SUH, Ji Kan RYU, Mi Hye KWON, Gou Young KOH